Search results for: Value-Based Pricing
Filter search results
OHE at AES: Medicines Prices in the UK, Health Inequalities in Costa Rica
25 June 2013
OHE’s participation at the 33rd Meeting of the Spanish Health Economics Association (AES) last week reported the results of four research projects. Jorge Mestre-Ferrandiz, OHE’s Director of Consulting, presented OHE’s…
Published: OHE Study Projecting UK Medicines Expenditure
30 September 2013
This research varies from other analyses in using a product-level, rather than a macro, approach. PharmacoEconomics has just published OHE’s study projecting medicines expenditure in the UK to 2015. (…
OHE Study Projecting UK Medicines Expenditure Extended to 2018
18 November 2013
…are based on the same methodology as in the PharmacoEconomics article. We will shortly publish an OHE Occasional Paper describing these results in greater detail. UK NHS Medicines Bill Projection:…
OHE Lunchtime Seminar on 23 February 2015: The Impact of Price-cap Regulations on Entry and Exit by Generic Pharmaceutical Firms in Canada
22 January 2015
OHE Lunchtime Seminar with Professor Aslam H. Anis, University of British Columbia, Vancouver’s Centre for Health Evaluation and Outcome Sciences and the CIHR Canadian HIV Trials Network. On Monday 23rd…
New Business Models for Antibiotics. What Can We Learn from Other Industries?
7 April 2015
The business model for antibiotics is broken. We looked at other industries facing conceptually similar challenges – particularly when the incentive for R&D is delinked from the volume of sales….
OHE Publishes in the Journal of Comparative Effectiveness Research: Future Expectations of Evidence of Relative Effectiveness in Europe and Comparative Effectiveness in the USA in 2020
15 April 2015
…to support key elements of value. In Europe, likewise, while there is development in non-experimental methods, multi-country registries, and increased acceptance of observational data by payers and regulators, both prefer…
Recently published: Are Wider Societal Effects Considered in Healthcare Decision-making?
29 February 2016
…based on a research study that was funded by Eli Lilly and Company. Download the full paper here. Full reference: Garau, M., Shah, K.K., Sharma, P. and Towse, A., 2016….
Two New Publications: ‘New Age Decision Making in HTA’ and ‘How Can HTA in Asia-Pacific Respond to Increased Clinical Uncertainty?’
6 September 2016
…Taiwanese perspective, explaining how conditional approval, with collection of post-marketing data alongside risk-sharing or pay-for-performance, is being explored locally. Finally, OHE’s Professor Adrian Towse explained how performance-based risk-sharing has been…
Important Variations in Access to Orphan Drugs in France, Italy, Germany, Spain and the UK
14 March 2017
A new OHE report compares the availability and access of orphan medicinal products (OMPs) in the UK, France, Germany, Italy and Spain. A new OHE Consulting Report has been published…